RESUMO
INTRODUCTION: Patients admitted from emergency units represent a large portion of the population in internal medicine departments. The aim of this study is to identify characteristics of patients and organization of these departments. METHODS: Between June 29th and July 26th 2015, voluntary internal medicine departments from the SiFMI group prospectively filled anonymized internet forms to collect data of each patients admitted in their ward from emergency units, during seven consecutive days. RESULTS: Three hundred and sixty-five patients from emergency departments were admitted in 18 internal medicine inpatients departments, totalling 1100 beds and 33,530 annual stays, 56% of them for emergency units inpatients. Mean age was 68 years, 54% were women, mean Charlson score was 2.6 and 44% of the patients took at least three drugs. Main causes of hospitalization were infectious (29%) and neurological (17%) diseases. Mean length of stay was 9.2 days. The medical team was composed by a median value of 4,5 [2,75-6,25] senior full-time equivalents, 86% were internists. Each department except one received residents, two third of them were from general medicine. CONCLUSION: This study highlights a high organizational variability among internal medicine departments and patients, and sets internal medicine as a specialty with a great capacity to achieve an integrative/comprehensive management of patients and to offer a comprehensive basis for physicians in training.
Assuntos
Serviço Hospitalar de Emergência , Medicina Interna , Idoso , Estudos Transversais , Feminino , Hospitalização , Hospitais , HumanosRESUMO
PURPOSE: To evaluate the influence of the chemical form of plutonium (Pu) on its distribution in tissues and within liver cells populations. MATERIALS AND METHODS: Groups of male Sprague-Dawley rats were contaminated by intravenous injection of either Pu citrate, Pu nitrate or Pu phytate. Pu content was determined in various tissues at different times after injection. Pu liver distribution was analysed by autoradiography and after cellular separation. RESULTS: Biokinetic studies indicate that Pu citrate and Pu nitrate predominantly retained in the skeleton within the first hours after injection, whereas most of the Pu was in the liver after injection of Pu phytate. Autoradiographs showed that Pu citrate was homogeneously distributed in the liver, while Pu nitrate accumulated into 'hot points'. Pu phytate showed an intermediate distribution pattern. Hepatic cell separation revealed a difference of uptake between the two cell types depending on the chemical form of injected Pu, and on the time after contamination. CONCLUSIONS: Distinct Pu behaviour was observed for biokinetics, retention and liver distribution. The large differences noted between citrate, nitrate and phytate might be explained by differences in systemic and hepatic transport.
Assuntos
Ácido Cítrico/farmacocinética , Nitratos/farmacocinética , Compostos Organometálicos/farmacocinética , Ácido Fítico/farmacocinética , Plutônio/farmacocinética , Animais , Carga Corporal (Radioterapia) , Cinética , Masculino , Taxa de Depuração Metabólica , Especificidade de Órgãos , Doses de Radiação , Ratos , Ratos Sprague-Dawley , Eficiência Biológica Relativa , Distribuição TecidualRESUMO
The aim of this study was to compare dissolution parameter values for Pu from industrial MOX with different Pu contents. For this purpose, preliminary results obtained after inhalation exposure of rats to MOX containing 2.5% Pu are reported and compared to those obtained previously with MOX containing 5% Pu. Dissolution parameter values appear to increase when the amount of Pu decreases. Rapid fractions, f(r), of 4 x 10(-3) (s.d. = 2 x 10(-3)) and 1 x 10(-3) (s.d. = 6 x 10(-4)) and slow dissolution rates, s(s) of 2 x 10(-4) d(-1) (standard deviation, sigma = 5 x 10(-5)) and 5 x 10(-5) d(-1) (sigma = 1 x 10(-5)) were derived for MOX containing 2.5 and 5% of Pu, respectively. Simulations were performed to assess uncertainties on dose due to experimental errors. The relative standard deviations of the dose per unit intake (DPUI) due to f(r) (4-8%), are far less than those due to s(s) (about 20%), which is the main parameter altering the dose. Although quite different dissolution parameter values were derived, similar DPUIs were obtained for MOX aerosols containing 2.5 and 5% Pu which appear close to that for default Type S values.
Assuntos
Poluentes Radioativos do Ar/farmacocinética , Pulmão/metabolismo , Óxidos/farmacocinética , Plutônio/farmacocinética , Radiometria/métodos , Absorção , Aerossóis , Poluentes Radioativos do Ar/análise , Animais , Simulação por Computador , Exposição por Inalação/análise , Masculino , Taxa de Depuração Metabólica , Modelos Biológicos , Óxidos/análise , Óxidos/classificação , Plutônio/análise , Plutônio/classificação , Doses de Radiação , Resíduos Radioativos/análise , Ratos , Ratos Sprague-Dawley , Reprodutibilidade dos Testes , Sensibilidade e EspecificidadeRESUMO
This study compares uncertainties of equivalent doses after internal contamination by 125I, 129I or 131I. Uncertainties were calculated using reported distributions of physiological parameters and Monte Carlo simulation. In adults, uncertainties increase from 131I to 125I and 129I with 1% of the population receiving 3.9, 4.0 and 7.2 times the median dose for the respective isotopes. In newborns, these values were 7.5, 12.3 and 19.0 for 131I, 125I and 129I respectively. The ratio of the beta dose delivered to the epithelium versus a homogeneous distributed dose was estimated for different iodine concentrations in colloid, epithelium and interstitium. In adults, for 131I, about 40% of the beta dose was delivered to the epithelial cells, whereas this fraction varied depending on the concentration for 125I and 129I, i.e. 20-30% at a relative epithelial concentration of 20% and 7-14% at a concentration of 3%. Small variations were observed depending on age.
Assuntos
Envelhecimento/fisiologia , Epitélio/metabolismo , Radioisótopos do Iodo/classificação , Radioisótopos do Iodo/farmacocinética , Modelos Biológicos , Radiometria , Glândula Tireoide/metabolismo , Absorção , Adolescente , Adulto , Fatores Etários , Criança , Pré-Escolar , Simulação por Computador , Humanos , Lactente , Recém-Nascido , Doses de Radiação , Reprodutibilidade dos Testes , Sensibilidade e EspecificidadeRESUMO
A new simple method is proposed to detect, using PET and [(11)C]raclopride, changes in striatal extracellular dopamine concentration during a rewarded effortful task. This approach aimed to increase the sensitivity in detection of these effects. It requires a single-dynamic PET study and combines the classic kinetic compartmental model with the general linear model of SPM to provide statistical inference on changes in [(11)C]raclopride time-activity curve due to endogenous dopamine release during two short periods of activation. Kinetic simulations predicted that 100% dopamine increase during two 5-min periods starting at 30 and 60 min after the injection can be detected. Moreover the effects of dopamine release on the [(11)C]raclopride time-activity-curve are different from those induced by CBF increase. These simulated curves were used to construct the statistical linear model and to test voxel-by-voxel in healthy subjects the hypothesis that dopamine is released in the ventral striatum during periods of unexpected monetary gains, but not during periods of unexpected monetary loss. The experimental results are in line with the expected results although the amplitude of the effects due to dopamine release is moderate. The advantages and the limits of this method as well as the relevance of the results for dopamine involvement in reward processing are discussed.
Assuntos
Corpo Estriado/metabolismo , Dopamina/metabolismo , Recompensa , Adulto , Corpo Estriado/diagnóstico por imagem , Corpo Estriado/efeitos dos fármacos , Antagonistas de Dopamina/farmacologia , Estudos de Viabilidade , Humanos , Cinética , Masculino , Modelos Neurológicos , Racloprida/farmacologia , Tomografia Computadorizada de EmissãoRESUMO
A review on specific parameter measurements to calculate doses per unit of incorporation according to recommendations of the International Commission of Radiological Protection has been performed for inhaled actinide oxides. Alpha activity distribution of the particles can be obtained by autoradiography analysis using aerosol sampling filters at the work places. This allows us to characterize granulometric parameters of "pure" actinide oxides, but complementary analysis by scanning electron microscopy is needed for complex aerosols. Dissolution parameters with their standard deviation are obtained after rat inhalation exposure, taking into account both mechanical lung clearance and actinide transfer to the blood estimated from bone retention. In vitro experiments suggest that the slow dissolution rate might decrease as a function of time following exposure. Dose calculation software packages have been developed to take into account granulometry and dissolution parameters as well as specific physiological parameters of exposed individuals. In the case of poorly soluble actinide oxides, granulometry and physiology appear as the main parameters controlling dose value, whereas dissolution only alters dose distribution. Validation of these software packages are in progress.
Assuntos
Elementos da Série Actinoide/toxicidade , Radiometria/métodos , Elementos da Série Actinoide/administração & dosagem , Elementos da Série Actinoide/química , Administração por Inalação , Aerossóis , SolubilidadeRESUMO
The aim of this work was to estimate risk of lung tumour occurrence after inhalation of actinide oxides from published studies and rat studies in progress. For the same delivered dose, the risk increases when homogeneity of irradiation increases, i.e., the number of particles deposited after inhalation increases (small particles and (or) low specific alpha activity). The dose-effect relationships reported appear linear up to a few gray, depending on the aerosol considered, and then the slope decreases. This slope, which corresponds with the risk, can vary over one order of magnitude depending on the aerosol used. An effective threshold at about 1 Gy was not observed for the most homogeneous dose distributions. A dosimetric and biological approach is proposed to provide a more realistic risk estimate.
Assuntos
Elementos da Série Actinoide/toxicidade , Carcinógenos/toxicidade , Neoplasias Pulmonares/patologia , Neoplasias Induzidas por Radiação/patologia , Administração por Inalação , Animais , Relação Dose-Resposta à Radiação , Ratos , Medição de RiscoRESUMO
BACKGROUND: Patients with familial amyloid polyneuropathy, a rare hereditary form of amyloidosis, have progressive autonomic neuropathy. The disease usually does not induce heart failure but is associated with sudden death, conduction disturbances, and an increased risk of complications during anesthesia. Although cardiac sympathetic denervation has been clearly demonstrated, the postsynaptic status of the cardiac autonomic nervous system remains unelucidated. METHODS AND RESULTS: Twenty-one patients were studied (age, 39+/-11 years; normal coronary arteries; left ventricular ejection fraction 68+/-9%). To evaluate the density and affinity constants of myocardial muscarinic receptors, PET with (11)C-MQNB (methylquinuclidinyl benzilate), a specific hydrophilic antagonist, was used. Cardiac beta-receptor functional efficiency was studied by the heart rate (HR) response to intravenous infusion of isoproterenol (5 minutes after 2 mg of atropine, 5, 10, and 15 ng/kg per minute during 5 minutes per step). The mean muscarinic receptor density was higher in patients than in control subjects (B'(max), 35.5+/-8.9 versus 26.1+/-6.7 pmol/mL, P=0.003), without change in receptor affinity. The increase in HR after injection of atropine as well as of MQNB was lower in patients compared with control subjects despite a similar basal HR (DeltaHR after atropine, 11+/-21% versus 62+/-17%; P<0.001), consistent with parasympathetic denervation. Incremental infusion of isoproterenol induced a similar increase in HR in patients and control subjects. CONCLUSIONS: Cardiac autonomic denervation in familial amyloid polyneuropathy results in an upregulation of myocardial muscarinic receptors but without change in cardiac beta-receptor responsiveness to catecholamines.
Assuntos
Neuropatias Amiloides Familiares/fisiopatologia , Isoproterenol/farmacologia , Miocárdio/metabolismo , Receptores Muscarínicos/efeitos dos fármacos , Simpatomiméticos/farmacologia , 3-Iodobenzilguanidina , Adulto , Idoso , Neuropatias Amiloides Familiares/patologia , Atropina/farmacologia , Pressão Sanguínea/efeitos dos fármacos , Relação Dose-Resposta a Droga , Ecocardiografia , Eletrocardiografia , Epinefrina/sangue , Feminino , Coração/diagnóstico por imagem , Coração/inervação , Coração/fisiopatologia , Frequência Cardíaca/efeitos dos fármacos , Ventrículos do Coração/efeitos dos fármacos , Ventrículos do Coração/metabolismo , Ventrículos do Coração/fisiopatologia , Humanos , Masculino , Pessoa de Meia-Idade , Norepinefrina/sangue , Cintilografia , Receptores Muscarínicos/fisiologiaRESUMO
The potential of positron emission tomography for the quantitative estimation of receptor concentration in extrastriatal regions has been limited in the past because of the low density of the D2 receptor sites in these regions and the insufficient affinity of the most widely used radioligands for dopamine receptors. The new method described in this paper permits the estimate of the D2 receptor concentration in the extrastriatal regions using a two-injection protocol and FLB 457, a ligand with a high affinity (20 pmol/L in vitro ) with D2 dopamine receptors. This approach is not valid for the striatal regions because some hypotheses cannot be verified (because of the high receptor concentration in these regions). The experimental protocol includes two injections with ligand doses designed to significantly occupy the extrastriatal receptor sites (approximately 90%), while leaving less than 60% of the receptor sites occupied by the ligand in the striatal regions. The results obtained using this double-saturation method are in line with the concentration estimates previously obtained using the multiinjection approach. The receptor concentration is 2.9 +/- 0.5 pmol/mL in the thalamus, 1.0 +/- 0.2 pmol/mL in the temporal cortex, and 0.35 +/- 0.13 pmol/mL in the occipital cortex. This study provides new arguments supporting the presence of a small receptor-site concentration in the cerebellum, estimated at 0.35 +/- 0.16 pmol/mL The simplicity of the calculation used to estimate the receptor concentration lends itself easily to parametric imaging. The receptor concentration is estimated pixel by pixel, without filtering. This method permits estimation of the extrastriatal D2 receptor concentration using an experimental protocol that can easily be used in patient studies (i.e., single experiment, no blood sampling, short experiment duration).
Assuntos
Encéfalo/diagnóstico por imagem , Antagonistas de Dopamina , Pirrolidinas , Receptores de Dopamina D2/metabolismo , Salicilamidas , Tomografia Computadorizada de Emissão/métodos , Encéfalo/metabolismo , Cerebelo/química , Cerebelo/diagnóstico por imagem , Cerebelo/metabolismo , Simulação por Computador , Corpo Estriado , Humanos , Ligantes , Modelos Biológicos , Receptores de Dopamina D2/análise , Lobo Temporal/química , Lobo Temporal/diagnóstico por imagem , Lobo Temporal/metabolismo , Tálamo/química , Tálamo/diagnóstico por imagem , Tálamo/metabolismoRESUMO
The results of several recent papers have shown a significant influence of the endogenous neurotransmitters on the exogenous ligand kinetics measured by positron emission tomography. For example, several groups found that the percentage of D2 receptor sites occupied by the endogenous dopamine ranged from 25% to 40% at basal level. An obvious consequence of this significant occupancy is that the ligand-receptor model parameters, usually estimated by a model that does not take into account the endogenous ligand (EL) kinetics, can be significantly biased. In the current work, the authors studied the biases obtained by using the multiinjection approach. The results showed that in the classical ligand-receptor model, the receptor concentration is correctly estimated and that only the apparent affinity is biased by not taking the EL into account. At present, all absolute quantifications of the EL have been obtained through pharmacologic manipulation of the endogenous transmitter concentration, which is often too invasive a method to be used in patients. A theoretical reasoning showed that a noninvasive approach is necessarily based on both the apparent affinity measurement and on a multiregion approach. The correlation between the receptor concentration and the apparent affinity, previously observed with some ligands, verifies these two conditions; thus, the authors suggest that this correlation could be the result of the EL effect. To test this assumption experimentally, the effect of reserpine-induced dopamine depletion on the interactions between the D2 receptor sites and the FLB 457 is studied. With untreated baboons, the apparent FLB 457 affinity was smaller in the receptor-rich regions (striatum) than in the receptor-poor regions. This discrepancy disappeared after dopamine depletion, strongly suggesting that this affinity difference was related to the EL effect. Therefore, the purpose of the current study was to test the ability to quantify the EL based on the observed correlation between the receptor concentration and the apparent affinity. This approach offers a method for estimating the percentage of receptor sites occupied by the EL and, if its affinity is known, the free EL concentration. From the data obtained using FLB 457 with baboons, the authors found that approximately 53% of the D2 receptor sites are occupied by dopamine in the striatum and that the free dopamine concentration is approximately 120 nmol/L at basal level. This approach is transferable to patients, because the experimental data are obtained without pharmacologically induced modification of the EL.
Assuntos
Encéfalo/metabolismo , Neurotransmissores/metabolismo , Receptores de Neurotransmissores/metabolismo , Tomografia Computadorizada de Emissão , Inibidores da Captação Adrenérgica/farmacologia , Animais , Sítios de Ligação , Dopamina/metabolismo , Antagonistas de Dopamina/metabolismo , Flumazenil/administração & dosagem , Flumazenil/metabolismo , Moduladores GABAérgicos/metabolismo , Humanos , Cinética , Ligantes , Matemática , Modelos Biológicos , Papio , Pirrolidinas/metabolismo , Receptores de Dopamina D2/metabolismo , Reserpina/farmacologia , Salicilamidas/metabolismoRESUMO
Receptor density and ligand affinity can be assessed using positron emission tomography (PET). Biological parameters (B(max)('), k(1), k(2), k(on)/V(R), k(off)) are estimated using a compartmental model and a multi-injection protocol. Parametric imaging of the ligand-receptor model has been shown to be of special interest to study certain brain disorders. However, the low signal-to-noise ratio in kinetic curves at the pixel level hampers an adequate estimation of model parameters during the optimization procedure. For this reason, mapping requires a spatial filter, resulting in a loss of resolution. Filtering the kinetic curves in the frequency domain using the Fourier transform is not appropriate, because of difficulties in choosing a correct and efficient cutoff frequency. A wavelet-based filter is more appropriate to such tracer kinetics. The purpose of this study is to build up parametric images at the pixel level while conserving the original spatial resolution, using wavelet-based filtering. Data from [(11)C]flumazenil studies, mapping the benzodiazepine receptor density, were used. An invertible discrete wavelet transform was used to calculate the time-frequency signals of the time-concentration PET curves on a pixel-by-pixel basis. Kinetic curves observed from large regions of interest in high and low receptor-density regions were used to calibrate the threshold of wavelet coefficients. The shrunken wavelet coefficients were then transformed back to the original domain in order to obtain the filtered PET signal. Maps of all binding parameters were obtained at the pixel level with acceptable coefficients of variation of less than 30% for the B(max)(') parameter in most of the gray matter. A strong correlation between model parameter estimates using the usual regions of interest and parametric imaging was observed for all model parameters (r = 0.949 for the parameter B(max)(')). We conclude that wavelet-based filters are useful for building binding parameter maps without loss of the original spatial resolution of the PET scanner. The use of the wavelet-based filtering method can be extended far beyond the multi-injection protocol. It is likely to be also effective for other dynamic PET studies.
Assuntos
Encéfalo/diagnóstico por imagem , Encéfalo/metabolismo , Modelos Biológicos , Receptores de GABA-A/metabolismo , Tomografia Computadorizada de Emissão , Simulação por Computador , Flumazenil/farmacocinética , Análise de Fourier , Moduladores GABAérgicos/farmacocinética , Humanos , Processamento de Imagem Assistida por Computador , Concentração Osmolar , Fatores de TempoRESUMO
The multi-injection approach has been used to study in baboon the in vivo interactions between the D2 receptor sites and FLB 457, a ligand with a very high affinity for these receptors. The model structure was composed of four compartments (plasma, free ligand, and specifically and unspecifically bound ligands) and seven parameters (including the D2 receptor site density). The arterial plasma concentration, after correction for metabolites, was used as the input function. The experimental protocol, which consisted of three injections of labeled and/or unlabeled ligand, allowed the evaluation of all model parameters from a single positron emission tomography experiment. In particular, the concentration of receptor sites available for binding (B'max) and the apparent in vivo FLB 457 affinity were estimated in seven brain regions, including the cerebellum and several cortex regions, in which these parameters are estimated in vivo for the first time (B'max is estimated to be 4.0+/-1.3 pmol/mL in the thalamus and from 0.32 to 1.90 pmol/mL in the cortex). A low receptor density was found in the cerebellum (B'max = 0.39+/-0.17 pmol/mL), whereas the cerebellum is usually used as a reference region assumed to be devoid of D2 receptor sites. In spite of this very small concentration (1% of the striatal concentration), and because of the high affinity of the ligand, we demonstrated that after a tracer injection, most of the PET-measured radioactivity in the cerebellum results from the labeled ligand bound to receptor sites. The estimation of all the model parameters allowed simulations that led to a precise knowledge of the FLB 457 kinetics in all brain regions and gave the possibility of testing the equilibrium hypotheses and estimating the biases introduced by the usual simplified approaches.
Assuntos
Cerebelo/metabolismo , Pirrolidinas/metabolismo , Receptores de Dopamina D2/metabolismo , Salicilamidas/metabolismo , Animais , Circulação Cerebrovascular/fisiologia , Antagonistas de Dopamina/metabolismo , Microinjeções , Lobo Occipital/metabolismo , Papio , Tomografia Computadorizada de Emissão , Córtex Visual/metabolismoRESUMO
BACKGROUND: Congestive heart failure is associated with decreased stimulated myocardial adenylate cyclase activity, increased Gi-binding protein, attenuated parasympathetic tone, and increased modulation of beta-adrenergic inotropic left ventricular stimulation by parasympathetic agonists. Despite these abnormalities, changes in the density or affinity of ventricular muscarinic receptors have not been demonstrated in patients. METHODS AND RESULTS: The density and affinity constants of myocardial muscarinic receptors were evaluated noninvasively by means of positron emission tomography with 11C-MQNB (methylquinuclidinyl benzilate), a specific hydrophilic antagonist, in 20 patients with congestive heart failure due to idiopathic dilated cardiomyopathy (mean left ventricular ejection fraction, 22+/-9%) and compared with values in 12 normal subjects. The mean receptor concentration was significantly higher in patients than in control subjects (B'max, 34.5+/-8.9 versus 25+/-7.7 pmol/mL, P<.005), with no changes in affinity constants. The change in heart rate after injection of 0.6 mg of cold MQNB was lower in patients than in control subjects (34+/-20% versus 55+/-36%, P<.05), and receptor density correlated negatively with maximal heart rate in the patients (r=.45, P<.05). CONCLUSIONS: Congestive heart failure is associated with an upregulation of myocardial muscarinic receptors. This may be an adaptive mechanism to beta-agonist stimulation and should increase the number of potential targets for pharmacological intervention.
Assuntos
Cardiomiopatia Dilatada/diagnóstico por imagem , Cardiomiopatia Dilatada/metabolismo , Miocárdio/metabolismo , Receptores Muscarínicos/metabolismo , Tomografia Computadorizada de Emissão , Adulto , Idoso , Cardiomiopatia Dilatada/fisiopatologia , Frequência Cardíaca/fisiologia , Humanos , Masculino , Pessoa de Meia-Idade , Valores de ReferênciaRESUMO
Positron emission tomography (PET) and single-photon emission computed tomography (SPECT) are the only functional imaging methodologies that allow to evaluate, in vivo in human, specific binding proteins such as receptors, transporters or enzymes. PET and SPECT have already proved to be unique tools to follow, in the living human brain, the kinetics of the interaction of a radiolabelled ligand with its receptors. However, these imaging techniques measure the radioligand concentration in regions of interest (ROIs) as a function of time but they do not allow the direct measurement of the binding parameters, i.e. receptor concentration and radioligand affinity. To estimate these physiological parameters a mathematical model must be designed to simulate the kinetics of the radioligand. The modelling of the data obtained using such equilibrium or dynamic models allow to extract from the kinetic data these physiological parameters. PET and SPECT imaging methodologies have then opened a new era in brain biochemistry and have already important applicants in brain physiopathology, clinical pharmacology and drug development.
Assuntos
Encéfalo/metabolismo , Compostos Radiofarmacêuticos/farmacocinética , Receptores de Superfície Celular/metabolismo , Tomografia Computadorizada de Emissão de Fóton Único , Tomografia Computadorizada de Emissão , HumanosRESUMO
The in vivo quantification of the benzodiazepine receptor concentration in human brain using positron emission tomography (PET) and 11C-flumazenil (11C-FMZ), is usually based on a three-compartment model and on PET curves measured in a small number of large regions of interest; however, it should be interesting to estimate the receptor concentration for each pixel and to build quantified images of the receptor concentration. The main advantage is to allow screening of the receptor site localization and visual observation of the possible abnormalities. Up to now, all the methods described include complex experimental protocols, difficult to use in routine examinations. In this paper, we propose the partial-saturation approach to obtain parametric images of benzodiazepine receptor concentration and FMZ affinity. It consists of a single FMZ injection with a low specific activity, followed by Scatchard analysis. Like other parametric imaging methods, this partial-saturation approach can lead to a small percentage (< 1%) of unrealistic values in receptor-poor regions; however, it is the only method that allows receptor concentration and affinity images to be obtained from a single-injection 40-min experiment without blood sampling. We also propose a second method in which the receptor concentration map is directly deduced from the PET image acquired 5 to 10 min after a partial-saturation injection. This method assumes a known and constant FMZ affinity value but requires only very simple corrections of this PET image. It is robust (negative values are never found) and quite simple to use in routine examination of patients (no blood sampling, single injection, only 10-min experiment).
Assuntos
Química Encefálica , Flumazenil , Moduladores GABAérgicos , Proteínas do Tecido Nervoso/análise , Receptores de GABA-A/análise , Tomografia Computadorizada de Emissão , Flumazenil/administração & dosagem , Flumazenil/metabolismo , Flumazenil/farmacocinética , Moduladores GABAérgicos/administração & dosagem , Moduladores GABAérgicos/metabolismo , Moduladores GABAérgicos/farmacocinética , Humanos , Processamento de Imagem Assistida por Computador , Modelos Biológicos , Proteínas do Tecido Nervoso/metabolismo , Receptores de GABA-A/metabolismoRESUMO
Positron emission tomography and compartmental models allow the in vivo analysis of radioligand binding to receptor sites in the human brain. Benzodiazepine receptor binding was studied using a three-compartmental model and [11C]flumazenil. Four and five parameters were estimated from a single kinetic curve obtained with a multi-injection protocol, and parametric maps of receptor density and of the individual kinetic parameters were created with four-pixel sampling of the experimental images. The coefficient of variation on each estimated model parameter was calculated using the diagonal elements of the covariance matrix. However, these estimates are valid only under some statistical hypotheses which are not always verified with PET data. Thus, in order to verify the validity of the coefficient of variation of each parameter calculated with the covariance matrix, these results have been compared with the more rigorous statistical results provided by a Monte Carlo simulation. The study showed a negligible difference between the results obtained by the two methods for a low noise level in time-concentration curves encountered using large ROIs. However, this bias becomes less negligible when the noise level is high and some estimations of the coefficients of variation were unacceptable (> 100%) with the five-parameter model. Such difficulties did not occur with the four-parameter model which led to parametric images with good quality and acceptable estimates of coefficients of variation (less than 20% in about 75% of the ROIs).
Assuntos
Encéfalo/diagnóstico por imagem , Encéfalo/metabolismo , Modelos Teóricos , Receptores de GABA-A/análise , Tomografia Computadorizada de Emissão/normas , Encefalopatias/diagnóstico por imagem , Encefalopatias/metabolismo , Radioisótopos de Carbono , Flumazenil/metabolismo , Humanos , Cinética , Ensaio Radioligante , Receptores de GABA-A/metabolismo , Reprodutibilidade dos TestesRESUMO
UNLABELLED: In vivo quantification of receptor concentration and ligand affinity using data obtained with PET is based on the compartmental analysis of ligand-receptor interactions. There is, however, an inconsistency between the assumed homogeneity of the ligand concentration in each compartment, a basic hypothesis of the compartmental analysis, and the obvious heterogeneity of the tissue. Our goal was to study the effects of the free ligand concentration heterogeneity on the parameters describing in vivo binding reaction and to introduce the concept of reaction volume, VR, to account for that heterogeneity. METHODS: The reaction volume is defined as the volume in which the free ligand mass present in 1 ml of tissue would have uniformly distributed with the same concentration as that in the vicinity of the receptor sites. The consequence of the heterogeneity of the free ligand concentration is that the equilibrium dissociation rate constant estimated from PET data corresponds to KdVR and not to Kd alone (defined by the ratio of the dissociation over the association rate constants). As a consequence, it is proposed to estimate the reaction volume as the ratio between the equilibrium dissociation constants obtained from in vivo and in vitro data (KdVR and Kd, respectively). RESULTS: We used data obtained from studies performed with eight different molecules and found a correlation between the reaction volume and the molecule lipophilicity. This correlation can be used as a method to estimate the order of magnitude of VR from the lipophilicity which is easily accessible experimentally. CONCLUSION: Reaction volume is an important parameter in in vivo ligand-receptor interaction modeling.
Assuntos
Ligantes , Receptores de Superfície Celular/análise , Tomografia Computadorizada de Emissão , Animais , Humanos , Modelos BiológicosRESUMO
UNLABELLED: The in vivo quantification of the benzodiazepine receptor concentration in humans using PET and flumazenil (FMZ) is usually based on Scatchard analysis when the goal is to avoid blood sampling. The experimental protocols, however, include several (at least two) experiments with various specific activities in the same subject to obtain a range of bound ligand concentrations. METHODS: We propose the partial saturation method, which is based on a natural decrease in bound ligand concentration after an FMZ injection with an average dose between a tracer dose and a saturation dose. An adequate range of bound ligand concentrations can thus be obtained from a single experiment. The free ligand concentration is estimated from the PET measurement in the pons after correction for the effect of the small receptor site concentration in this reference region. RESULTS: The receptor concentration and affinity estimates obtained with this approach in six regions of interest agree with previously published values obtained by using more complex approaches. Receptor concentration appears to be insensitive to the uncertainties with regard to the receptor site concentration in the pons. CONCLUSION: The partial saturation protocol can be used to estimate both the benzodiazepine receptor concentration and the FMZ affinity in routine examinations in adults (or even in children) using a single 40-min experiment without blood sampling.